中财网 中财网股票行情
拓新药业(301089)财务分析指标    年份：
截止日期2025-06-302025-03-312024-12-312024-09-302024-06-30
营业总收入(万元)18189.989699.4742169.4132575.3721875.67
营业收入(万元)18189.989699.4742169.4132575.3721875.67
营业总成本(万元)20228.3710416.7645944.1034630.3722834.92
营业成本(万元)12512.676725.8429574.6624207.7716505.14
净利润(万元)-1828.05-356.47-1911.57-265.38-177.93
归属于母公司的净利润(万元)-1828.05-356.47-1988.49-265.38-177.93
营业利润(万元)-2105.58-373.45-2371.82-714.88-114.87
利润总额(万元)-2143.13-396.83-2773.25-1089.72-133.33
少数股东损益(万元)----------
基本每股收益(元)-0.14(元)-0.03(元)-0.16(元)-0.02(元)-0.01(元)
稀释每股收益(元)-0.14(元)-0.03(元)-0.16(元)-0.02(元)-0.01(元)
非经常性损益(万元)--238.79737.05768.82618.77
扣除非经常性损益后净利润(万元)-2220.76-595.27-2725.54-1034.19-796.70
总资产(万元)170723.00175169.37175824.39174658.97176862.92
总负债(万元)17299.0520273.8420572.3917760.7719877.28
归属于母公司股东权益合计(万元)153423.95154895.53155252.01156898.20156985.64
股东权益合计(万元)153423.95154895.53155252.01156898.20156985.64
实收资本(股本)(万元)12654.4512654.4512654.4512654.4512654.45
资本公积(万元)62111.0062111.0062111.0062111.0062111.00
未分配利润(万元)71915.2673386.8473743.3175466.4275553.87
经营活动产生的现金流量净额(万元)-2301.46-2801.0510266.8710912.895995.98
经营活动现金流入小计(万元)16104.687406.3641806.9936398.4324474.56
经营活动现金流出小计(万元)18406.1410207.4231540.1225485.5418478.59
投资活动产生的现金流量净额(万元)1898.1211124.24-13987.61-1408.75902.73
投资活动现金流入小计(万元)47257.8834188.7361403.6246314.6826203.37
投资活动现金流出小计(万元)45359.7623064.4975391.2347723.4325300.64
筹资活动产生的现金流量净额(万元)-----3257.29-3154.46-3158.34
筹资活动现金流入小计(万元)------9.155.27
筹资活动现金流出小计(万元)----3257.293163.613163.61
期末现金及现金等价物余额(万元)5787.9914519.726178.1719429.1916871.42
最后修改日期2025-08-272025-04-292025-04-292024-10-292024-08-26
↑返回页顶↑

转至拓新药业（301089）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。